Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Facioscapulohumeral Muscular Dystrophy: Genetics and Trials
View through CrossRef
A complex combination of molecular pathways and cell interactions causes facioscapulohumeral muscular dystrophy (FSHD). Several new therapies pose a promising solution to this disease with no cure. This chapter aims to explain the genetics of facioscapulohumeral muscular dystrophy, and review the current clinical trials for the treatment of FSHD.
Title: Facioscapulohumeral Muscular Dystrophy: Genetics and Trials
Description:
A complex combination of molecular pathways and cell interactions causes facioscapulohumeral muscular dystrophy (FSHD).
Several new therapies pose a promising solution to this disease with no cure.
This chapter aims to explain the genetics of facioscapulohumeral muscular dystrophy, and review the current clinical trials for the treatment of FSHD.
Related Results
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Background Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians to perform an adequate diagnosis. Ma...
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Diagnostic strategies for muscular dystrophies: a cross-sectional study
Background:
Muscular dystrophies are a wide heterogeneity group of neuromuscular diseases that very often constitutes a challenge for clinicians to perform an ...
Challenges in developing gene therapy against Duchenne muscular dystrophy
Challenges in developing gene therapy against Duchenne muscular dystrophy
Duchenne muscular dystrophy is a progressive X-linked recessive neuromuscular disorder resulting from pathogenic mutations in the DMD gene, which codes dystrophin. It is one of the...
Clinico-pathological Diagnosis of Facioscapulohumeral Dystrophy in a 22-year-old Male
Clinico-pathological Diagnosis of Facioscapulohumeral Dystrophy in a 22-year-old Male
Background: Facioscapulohumeral dystrophy (FSHD) is a rare hereditary disease with a prevalence of 2.03–6.8 per 100,000 individuals. FSHD is the third most common type of muscular ...
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
Background
Cardiomyopathy is a leading cause of mortality among Duchenne muscular dystrophy patients and lacks effective therapies. Phosphodiesterase type 5 is ...
Advanced Physiotherapy Intervention for Muscular Dystrophy
Advanced Physiotherapy Intervention for Muscular Dystrophy
Muscular dystrophies are rare neuromuscular conditions which are genetically and clinically diverse that cause gradual, progressive weakness and breakdown of skeletal muscles over ...
Real-world experience with gene therapy in Duchenne muscular dystrophy center readiness and patients safety: report from Qatar
Real-world experience with gene therapy in Duchenne muscular dystrophy center readiness and patients safety: report from Qatar
Abstract
Duchenne Muscular Dystrophy is a rare, X-linked neuromuscular disorder that leads to progressive muscle degeneration, loss of ambulation, and premature m...
Duchene’s muscular dystrophy: a clinical case
Duchene’s muscular dystrophy: a clinical case
Background. Muscular dystrophy is a heterogeneous group of genetic disorders characterized by progressive loss of skeletal muscles. Duchene's muscular dystrophy (MDD) is one of the...